Evidence map›Paper›PMID 38449810›Full record

ReviewFrontiers in pharmacology2024

Established and emerging GABA

Robert J Richardson, Steven Petrou, Alexander Bryson

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 32 citations in OpenAlex.

  1. Pharmaceutical biology · 2026
    Review
  2. Article
  3. GABASynapse (New York, N.Y.) · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. A pore-facing glycan constrains GABACommunications biology · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Infantile epileptic spasms syndrome: Mechanisms and therapeutic approaches.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Review
  12. Article
  13. Carvone derived cannabidiol enantiomers as novel anticonvulsants.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  14. Review
  15. Article
  16. Φ value analysis underscores strong functional and structural compactness of the GABAProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  17. Beyond epilepsy: The expanding role of valproic acid in Alzheimer disease therapy - a review.The Journal of pharmacology and experimental therapeutics · 2025
    Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Robert J RichardsonFlorey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, VIC, Australia.
Steven PetrouFlorey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, VIC, Australia.
Alexander BrysonFlorey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, VIC, Australia.
Florey Institute of Neuroscience and Mental Health · AUPraxis (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drugs that modulate the GABA

Indexed as

antisensebenzodiazepinesepilepsyGABA allosteric modulators aGABA A receptorneurosteriodoligonucleotide-drug conjugates

Identifiers

PMID38449810
PMCPMC10915249
OpenAlexW4392001987

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.